A detailed history of Studio Investment Management LLC transactions in Amgen Inc stock. As of the latest transaction made, Studio Investment Management LLC holds 12,276 shares of AMGN stock, worth $3.24 Million. This represents 0.86% of its overall portfolio holdings.

Number of Shares
12,276
Previous 12,696 3.31%
Holding current value
$3.24 Million
Previous $3.97 Million 0.28%
% of portfolio
0.86%
Previous 0.92%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$309.38 - $337.38 $129,939 - $141,699
-420 Reduced 3.31%
12,276 $3.96 Million
Q2 2024

Aug 07, 2024

BUY
$262.75 - $319.31 $109,829 - $133,471
418 Added 3.4%
12,696 $3.97 Million
Q1 2024

May 15, 2024

SELL
$268.87 - $324.56 $166,699 - $201,227
-620 Reduced 4.81%
12,278 $3.49 Million
Q4 2023

Feb 15, 2024

BUY
$255.7 - $288.46 $118,133 - $133,268
462 Added 3.72%
12,898 $3.71 Million
Q3 2023

Nov 15, 2023

BUY
$218.65 - $271.46 $306,984 - $381,129
1,404 Added 12.73%
12,436 $3.34 Million
Q2 2023

Aug 14, 2023

BUY
$214.27 - $253.37 $128,990 - $152,528
602 Added 5.77%
11,032 $2.45 Million
Q1 2023

May 15, 2023

SELL
$225.79 - $275.2 $86,477 - $105,401
-383 Reduced 3.54%
10,430 $2.52 Million
Q4 2022

Feb 14, 2023

SELL
$229.03 - $291.01 $89,779 - $114,075
-392 Reduced 3.5%
10,813 $2.84 Million
Q3 2022

Nov 14, 2022

SELL
$224.46 - $253.15 $903,451 - $1.02 Million
-4,025 Reduced 26.43%
11,205 $2.53 Million
Q2 2022

Aug 15, 2022

SELL
$230.71 - $256.74 $276,852 - $308,088
-1,200 Reduced 7.3%
15,230 $3.71 Million
Q1 2022

May 16, 2022

SELL
$219.27 - $242.57 $488,972 - $540,931
-2,230 Reduced 11.95%
16,430 $3.97 Million
Q4 2021

Feb 14, 2022

BUY
$198.88 - $227.6 $401,538 - $459,524
2,019 Added 12.13%
18,660 $4.2 Million
Q3 2021

Nov 15, 2021

BUY
$212.27 - $248.7 $3.53 Million - $4.14 Million
16,641 New
16,641 $3.54 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Studio Investment Management LLC Portfolio

Follow Studio Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Studio Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Studio Investment Management LLC with notifications on news.